RARbeta2 specificity in mediating RA inhibition of growth of lung cancer-derived cells

A Toulouse1, J Morin, P A Dion

  • 1Centre de Recherche du CHUM, Pavillon Notre-Dame, 1560 Sherbrooke E., Montréal, Canada. mbem@musica.mcgill.ca

Insights

Retinoic acid receptor beta 2 (RARbeta2) specifically suppresses lung cancer cell growth. Other retinoic acid receptor isoforms, like RARalpha1 and RARbeta1, do not exhibit this same tumor-suppressive effect.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Retinoic acid receptor beta (RARbeta) is linked to growth suppression in epithelial tumors.
  • RARbeta2 has previously shown potential in reducing lung tumor cell growth and tumorigenicity.
  • The isoform specificity of this growth suppressive effect remained unclear.

Purpose of the Study:

  • To investigate the isoform specificity of retinoic acid receptor (RAR)-mediated growth suppression in lung cancer.
  • To determine if RARalpha1, RARbeta1, or RARbeta2 isoforms mediate the growth suppressive effects of retinoic acid.

Main Methods:

  • Transfection of RARalpha1, RARbeta1, and RARbeta2 into the Calu-1 epidermoid lung cancer cell line.
  • Assessment of in vitro growth capacities of transfected lung cancer cells.
  • Analysis of RARalpha2 expression patterns in various tumor-derived cell lines.

Main Results:

  • RARbeta2 transfection significantly reduced in vitro growth of Calu-1 cells in the presence of retinoic acid.
  • Expression of RARbeta1 or RARalpha1 isoforms did not replicate the growth suppressive effect of RARbeta2.
  • RARalpha2 expression patterns suggest it is not involved in retinoic acid-mediated growth suppression of lung cancer.

Conclusions:

  • The growth suppressive effect of retinoic acid in lung cancer is RARbeta2 isoform specific.
  • RARbeta1 and RARalpha1 isoforms do not mediate the observed tumor suppressive effects.
  • RARbeta2 represents a specific therapeutic target for retinoic acid-driven lung cancer growth inhibition.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: